BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs6983267
,
PRKCA
,
Metabolism of xenobiotics
,
Allergy to pollen
,
Leukocyte
,
Aspirin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Interleukin-12 beta, central domain
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Loading...
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Legionella infection
Bacterial infection due to Bacillus
Infection due to Mycobacterium tuberculosis
Salmonella infection
Listeriosis
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Oligodeoxyribonucleotides
5'-Guanylic Acid
Lipopeptides
argingipain, Porphyromonas gingivalis
Galectin 1
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
IRAK4
RASSF2
TRU-TCA1-1
NDUFB8
F12
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Bone marrow- and peritoneal-derived mouse macrophages in resonse to a timecourse of LPS treatment
CpG-mediated changes in gene expression
Macrophage-mediated clearance of apoptotic cells in response to complement component C1q
OMIM - Immunodeficiency disorder
The Immunological Genome Project - Immune cell lineage differentiation and maturation
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for Interleukin-12 beta, central domain
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus …
Phase I/II Trial Investigating the Safety, Tolerability, Pharmacokinetics, Immune and Clinical Activ…
Clinical Trial of CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLC
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating W…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ